Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 21;82(8):1441–1445. doi: 10.1054/bjoc.1999.1074

Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour

H E Turner 1, Zs Nagy 2,3, K C Gatter 4, M M Esiri 2, J A H Wass 1, A L Harris 5
PMCID: PMC2363363  PMID: 10780524

Abstract

The prediction of pituitary tumour behaviour, in terms of response to treatment from which can be derived optimal management strategies, is a challenge that has been approached using several different means. Angiogenesis in other tumour types has been shown to be correlated with poor response to treatment and tumour recurrence. The aim of this paper is to assess the role of measurements of cell proliferation and angiogenesis in predicting pituitary tumour behaviour. The proliferative capacity of the tumour was assessed using the Ki-67 labelling index (LI) while bcl-2 expression was used to assess anti-apoptotic pathways. The microvessel density (MVD) was assessed using antibodies to CD31 and factor VIII-related antigen, and with biotinylated ulex europaeus agglutinin I. There was no difference between Ki-67 LI and MVD of functionless tumours that recurred and those that did not, but bcl-2 expression was significantly lower in tumours that subsequently regrew. Macroprolactinomas had significantly higher LI than microprolactinomas and than all other tumours. Cell proliferation and angiogenesis were not related, showing that both processes are under different control mechanisms in pituitary tumours. In contrast there was a positive relationship between markers of angiogenesis and bcl-2 expression in prolactinomas, GH-secreting tumours and non-recurrent functionless tumours with higher levels of bcl-2 expression being found in the more vascular tumours. These findings may suggest that angiogenesis is related to the ability of tumour cells to survive rather than their proliferative activity. © 2000 Cancer Research Campaign

Keywords: angiogenesis, proliferation, apoptosis, pituitary tumour, bcl-2

Full Text

The Full Text of this article is available as a PDF (94.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe T., Sanno N., Osamura Y. R., Matsumoto K. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochir (Wien) 1997;139(7):613–618. doi: 10.1007/BF01411995. [DOI] [PubMed] [Google Scholar]
  2. Berardo M. D., Elledge R. M., de Moor C., Clark G. M., Osborne C. K., Allred D. C. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer. 1998 Apr 1;82(7):1296–1302. [PubMed] [Google Scholar]
  3. Blagosklonny M. V., An W. G., Romanova L. Y., Trepel J., Fojo T., Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem. 1998 May 15;273(20):11995–11998. doi: 10.1074/jbc.273.20.11995. [DOI] [PubMed] [Google Scholar]
  4. Bochner B. H., Cote R. J., Weidner N., Groshen S., Chen S. C., Skinner D. G., Nichols P. W. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst. 1995 Nov 1;87(21):1603–1612. doi: 10.1093/jnci/87.21.1603. [DOI] [PubMed] [Google Scholar]
  5. Carmeliet P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998 Jul 30;394(6692):485–490. doi: 10.1038/28867. [DOI] [PubMed] [Google Scholar]
  6. Charpin C., Garcia S., Bonnier P., Martini F., Andrac L., Horschowski N., Lavaut M. N., Allasia C. bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up. J Clin Oncol. 1998 Jun;16(6):2025–2031. doi: 10.1200/JCO.1998.16.6.2025. [DOI] [PubMed] [Google Scholar]
  7. Christofori G., Naik P., Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol. 1995 Dec;9(12):1760–1770. doi: 10.1210/mend.9.12.8614412. [DOI] [PubMed] [Google Scholar]
  8. Dameron K. M., Volpert O. V., Tainsky M. A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994 Sep 9;265(5178):1582–1584. doi: 10.1126/science.7521539. [DOI] [PubMed] [Google Scholar]
  9. Delgrange E., Trouillas J., Maiter D., Donckier J., Tourniaire J. Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab. 1997 Jul;82(7):2102–2107. doi: 10.1210/jcem.82.7.4088. [DOI] [PubMed] [Google Scholar]
  10. Fan L., Iseki S. Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat. Arch Histol Cytol. 1998 Mar;61(1):17–28. doi: 10.1679/aohc.61.17. [DOI] [PubMed] [Google Scholar]
  11. Fontanini G., Vignati S., Bigini D., Mussi A., Lucchi M., Angeletti C. A., Basolo F., Bevilacqua G. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer. 1995 May;71(5):1003–1007. doi: 10.1038/bjc.1995.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fox S. B., Gatter K. C., Bicknell R., Going J. J., Stanton P., Cooke T. G., Harris A. L. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 1993 Sep 15;53(18):4161–4163. [PubMed] [Google Scholar]
  13. Fox S. B., Leek R. D., Weekes M. P., Whitehouse R. M., Gatter K. C., Harris A. L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol. 1995 Nov;177(3):275–283. doi: 10.1002/path.1711770310. [DOI] [PubMed] [Google Scholar]
  14. Frank R. E., Saclarides T. J., Leurgans S., Speziale N. J., Drab E. A., Rubin D. B. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg. 1995 Dec;222(6):695–699. doi: 10.1097/00000658-199512000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gasparini G., Weidner N., Bevilacqua P., Maluta S., Dalla Palma P., Caffo O., Barbareschi M., Boracchi P., Marubini E., Pozza F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol. 1994 Mar;12(3):454–466. doi: 10.1200/JCO.1994.12.3.454. [DOI] [PubMed] [Google Scholar]
  16. Hockenbery D. M. The bcl-2 oncogene and apoptosis. Semin Immunol. 1992 Dec;4(6):413–420. [PubMed] [Google Scholar]
  17. Holthöfer H., Virtanen I., Kariniemi A. L., Hormia M., Linder E., Miettinen A. Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest. 1982 Jul;47(1):60–66. [PubMed] [Google Scholar]
  18. Jin L., Qian X., Kulig E., Sanno N., Scheithauer B. W., Kovacs K., Young W. F., Jr, Lloyd R. V. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol. 1997 Aug;151(2):509–519. [PMC free article] [PubMed] [Google Scholar]
  19. Knosp E., Kitz K., Perneczky A. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery. 1989 Dec;25(6):927–930. [PubMed] [Google Scholar]
  20. Knowlton K., Mancini M., Creason S., Morales C., Hockenbery D., Anderson B. O. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect. J Surg Res. 1998 Apr;76(1):22–26. doi: 10.1006/jsre.1998.5277. [DOI] [PubMed] [Google Scholar]
  21. Landis J. R., Koch G. G. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159–174. [PubMed] [Google Scholar]
  22. Maeda K., Chung Y. S., Takatsuka S., Ogawa Y., Sawada T., Yamashita Y., Onoda N., Kato Y., Nitta A., Arimoto Y. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol. 1995 Feb;13(2):477–481. doi: 10.1200/JCO.1995.13.2.477. [DOI] [PubMed] [Google Scholar]
  23. Mukai K., Rosai J., Burgdorf W. H. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol. 1980 Jun;4(3):273–276. doi: 10.1097/00000478-198006000-00008. [DOI] [PubMed] [Google Scholar]
  24. Nagy Z., Esiri M. M., Smith A. D. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol. 1997 Mar;93(3):294–300. doi: 10.1007/s004010050617. [DOI] [PubMed] [Google Scholar]
  25. Nör J. E., Christensen J., Mooney D. J., Polverini P. J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol. 1999 Feb;154(2):375–384. doi: 10.1016/S0002-9440(10)65284-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Terris B., Scoazec J. Y., Rubbia L., Bregeaud L., Pepper M. S., Ruszniewski P., Belghiti J., Fléjou J., Degott C. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology. 1998 Feb;32(2):133–138. doi: 10.1046/j.1365-2559.1998.00321.x. [DOI] [PubMed] [Google Scholar]
  27. Thapar K., Kovacs K., Scheithauer B. W., Stefaneanu L., Horvath E., Pernicone P. J., Murray D., Laws E. R., Jr Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery. 1996 Jan;38(1):99–107. doi: 10.1097/00006123-199601000-00024. [DOI] [PubMed] [Google Scholar]
  28. Thapar K., Scheithauer B. W., Kovacs K., Pernicone P. J., Laws E. R., Jr p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery. 1996 Apr;38(4):765–771. [PubMed] [Google Scholar]
  29. Turner H. E., Wass J. A. Are markers of proliferation valuable in the histological assessment of pituitary tumours? Pituitary. 1999 May;1(3-4):147–151. doi: 10.1023/a:1009979128608. [DOI] [PubMed] [Google Scholar]
  30. Vartanian R. K., Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol. 1994 Jun;144(6):1188–1194. [PMC free article] [PubMed] [Google Scholar]
  31. Vermeulen P. B., Dirix L. Y., Libura J., Vanhoolst I. F., Van Marck E., Van Oosterom A. T. Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel density. Microvasc Res. 1997 Jul;54(1):88–92. doi: 10.1006/mvre.1997.2019. [DOI] [PubMed] [Google Scholar]
  32. Vermeulen P. B., Gasparini G., Fox S. B., Toi M., Martin L., McCulloch P., Pezzella F., Viale G., Weidner N., Harris A. L. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996 Dec;32A(14):2474–2484. doi: 10.1016/s0959-8049(96)00379-6. [DOI] [PubMed] [Google Scholar]
  33. Wang D. G., Johnston C. F., Atkinson A. B., Heaney A. P., Mirakhur M., Buchanan K. D. Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc. J Clin Pathol. 1996 Oct;49(10):795–797. doi: 10.1136/jcp.49.10.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E. N., Moore D. H., Meli S., Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992 Dec 16;84(24):1875–1887. doi: 10.1093/jnci/84.24.1875. [DOI] [PubMed] [Google Scholar]
  35. Weidner N. Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer. 1996 Dec;32A(14):2506–2512. doi: 10.1016/s0959-8049(96)00378-4. [DOI] [PubMed] [Google Scholar]
  36. Weidner N., Semple J. P., Welch W. R., Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991 Jan 3;324(1):1–8. doi: 10.1056/NEJM199101033240101. [DOI] [PubMed] [Google Scholar]
  37. Witt M., Klessen C. Galactose and fucose binding sites in anterior pituitary cells of the rat. Detection by means of biotinylated lectins. Folia Histochem Cytobiol. 1987;25(2):115–118. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES